• 1. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 2. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 3. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 4. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 5. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864

Recent Advances in the Application of 5-Amino-1H-pyrazole-3-carboxylic acid (CAS: 124004-31-5) in Chemical Biology and Pharmaceutical Research

5-Amino-1H-pyrazole-3-carboxylic acid (CAS: 124004-31-5) is a heterocyclic compound that has garnered significant attention in chemical biology and pharmaceutical research due to its versatile applications as a building block for drug discovery and development. Recent studies have highlighted its potential in the synthesis of novel bioactive molecules, particularly in the areas of kinase inhibition, antimicrobial agents, and anticancer therapeutics. This research brief aims to summarize the latest findings related to this compound, focusing on its chemical properties, synthetic applications, and biological activities.

One of the key areas of interest is the role of 5-Amino-1H-pyrazole-3-carboxylic acid in the design of kinase inhibitors. Kinases are critical targets in the treatment of various diseases, including cancer and inflammatory disorders. Recent research has demonstrated that derivatives of this compound exhibit potent inhibitory activity against specific kinases, such as cyclin-dependent kinases (CDKs) and Janus kinases (JAKs). For instance, a 2023 study published in the Journal of Medicinal Chemistry reported the synthesis of a series of pyrazole-based CDK inhibitors, with 5-Amino-1H-pyrazole-3-carboxylic acid serving as a core scaffold. These inhibitors showed promising antitumor activity in preclinical models, underscoring the compound's potential in oncology drug development.

In addition to its applications in kinase inhibition, 5-Amino-1H-pyrazole-3-carboxylic acid has been explored for its antimicrobial properties. A recent study in Bioorganic & Medicinal Chemistry Letters (2024) described the synthesis of pyrazole-carboxylic acid hybrids with enhanced antibacterial activity against multidrug-resistant strains. The study revealed that the incorporation of this compound into hybrid molecules significantly improved their binding affinity to bacterial targets, such as DNA gyrase and topoisomerase IV. These findings suggest that 5-Amino-1H-pyrazole-3-carboxylic acid could play a pivotal role in addressing the global challenge of antibiotic resistance.

Another noteworthy application of this compound is in the field of anticancer drug discovery. Researchers have utilized 5-Amino-1H-pyrazole-3-carboxylic acid as a precursor for the synthesis of small molecules that target tumor-specific pathways. For example, a 2024 study in the European Journal of Medicinal Chemistry demonstrated that pyrazole-based compounds derived from this scaffold exhibited selective cytotoxicity against cancer cells while sparing normal cells. The study attributed this selectivity to the compound's ability to modulate reactive oxygen species (ROS) levels and induce apoptosis in malignant cells. These results highlight the compound's potential as a lead structure for the development of next-generation anticancer agents.

From a synthetic chemistry perspective, 5-Amino-1H-pyrazole-3-carboxylic acid offers several advantages, including its stability, ease of functionalization, and compatibility with diverse reaction conditions. Recent advancements in synthetic methodologies have enabled the efficient modification of this compound to yield a wide array of derivatives with tailored biological activities. For instance, a 2023 publication in Organic Letters detailed a novel one-pot synthesis route for pyrazole-carboxylic acid derivatives, which significantly reduced the number of steps and improved overall yields. Such innovations are expected to accelerate the exploration of this compound's full potential in drug discovery.

In conclusion, 5-Amino-1H-pyrazole-3-carboxylic acid (CAS: 124004-31-5) continues to be a valuable scaffold in chemical biology and pharmaceutical research. Its applications span multiple therapeutic areas, including kinase inhibition, antimicrobial therapy, and anticancer drug development. Recent studies have not only expanded our understanding of its biological activities but also advanced synthetic strategies to harness its full potential. As research in this field progresses, this compound is likely to remain a focal point for the discovery of novel therapeutic agents.

• 120854-58-2(3-PYRIDAZINECARBOXYLIC ACID, 6-AMINO-, HYDROCHLORIDE)
• 117860-53-4(5-amino-1-methyl-pyrazole-3-carboxylic acid)
• 948571-48-0((3-Amino-1H-pyrazol-5-yl)methanol)
• 1000895-26-0((3-Amino-1H-pyrazol-5-yl)methanol)
• 105434-90-0(Ethyl 5-amino-1H-pyrazole-3-carboxylate)
• 59772-58-6(6-Aminopyridazine-3-carboxylic acid)
• 632365-54-9(methyl 3-amino-1H-pyrazole-5-carboxylate)
• 117860-54-5(3-Amino-1-methyl-1H-pyrazole-5-carboxylic acid)
• 1092683-01-6(3-Amino-4-bromo-1H-pyrazole-5-carboxylic acid)
• 351990-74-4(5-amino-4-bromo-1H-pyrazole-3-carboxylic Acid)